Top 5 Takeaways High Impact on MSM: Gay, bisexual, and other men who have sex with men (MSM), particularly Black MSM, were the most affected by the 2022 U.S. monkeypox

Top 5 Takeaways Pronounced Disparities: From April to July 2022, Paxlovid treatment among COVID-19 patients aged ≥20 years was significantly lower for Black (35.8% less) and Hispanic (29.9% less) patients

Top 5 Takeaways Influenza A(H3N2) virus, specifically clade 3C.2a1b.2a.2, emerged in Chile much earlier than in pre-pandemic seasons, resulting in 1,002 hospitalizations in 2022. The influenza vaccination was found to

Top 5 Takeaways Wastewater Testing Identified PV2 in New York: Wastewater testing in New York detected poliovirus type 2 (PV2), genetically related to the virus from a paralytic polio case

Top 5 Takeaways High Volume of Prescriptions: In 2021, 6.5 million topical antifungal prescriptions, costing $231 million, were filled for Medicare Part D beneficiaries, equating to approximately one prescription for

Top 5 Takeaways New and Updated Vaccine Recommendations: The 2024 immunization schedule includes key changes, notably for influenza, pneumococcal vaccines, RSV monoclonal antibody (RSV-mAb), respiratory syncytial virus vaccines (RSV), COVID-19

Top 5 Takeaways New and Updated Vaccine Recommendations: The 2024 schedule includes changes for respiratory syncytial virus (RSV), influenza, COVID-19, inactivated poliovirus vaccine (IPV), Mpox vaccine, and meningococcal vaccines. Removal

Top 5 Takeaways Bivalent mRNA COVID-19 Vaccine Effectiveness: The bivalent mRNA COVID-19 vaccine was found to be 47% effective in preventing thromboembolic events in immunocompetent persons aged ≥65 years and

Top 5 Takeaways Among 57 patients hospitalized for severe monkeypox during the study period, most were Black men with AIDS, highlighting the severe impact of monkeypox in immunocompromised individuals. Twelve

Top 5 Takeaways Prevalence and Demographics: Monkeypox virus (MPXV) infections in children and adolescents aged <18 years constituted only 0.3% of all U.S. cases during the study period, with no